You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 5,908,824

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,908,824

Title:	Nasally administrable compositions containing physiologically active peptides
Abstract:	A nasally administrable composition having a physiologically active peptide dispersed homogeneously in and adsorbed homogeneously onto a unique carrier. The composition contains an effective amount of physiologically active peptide dispersed homogeneously in and adsorbed homogeneously onto a mucosa protecting and/or tissue repairing agent, e.g., gefarnate, aceglutamide aluminum, sucralfate, L-glutamine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, cetraxate or troxipide.
Inventor(s):	Yanagawa; Akira (Yokohama, JP)
Assignee:	Dott Research Laboratory (Yokohama, JP)
Application Number:	08/733,065
Patent Claims:	1. A nasally administrable composition containing a physiologically active peptide, wherein an effective amount of the physiologically active peptide is dispersed homogeneously in and adsorbed homogeneously onto one or more gastric mucosa protecting or gastric mucosa tissue repairing agents selected from the group consisting of gefarnate, aceglutamide aluminum, sucralfate, L-glutamine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, and troxipide. 2. A nasally administrable composition according to claim 1 wherein the physiologically active peptide is a peptide hormone, a physiologically active protein, an enzymatic protein, or an opioid peptide. 3. A nasally administrable composition according to claim 1 wherein the physiologically active peptide is calcitonin, insulin, parathyroid hormone, human growth hormone, gonadotropin-releasing hormone or a derivative thereof. 4. A nasally administrable composition wherein calcitonin is dispersed homogeneously in and adsorbed homogeneously onto one or more gastric mucosa protecting or gastric mucosa tissue repairing agents selected from the group consisting of gefarnate, aceglutamide aluminum, sucralfate, L-glutamine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, and troxipide. 5. A nasally administrable composition wherein parathyroid hormone is dispersed homogeneously in and adsorbed homogeneously onto one or more gastric mucosa protecting or gastric mucosa tissue repairing agents selected from the group consisting of gefarnate, aceglutamide aluminum, sucralfate, L-glutamine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, and troxipide. 6. A nasally administrable composition wherein gonadotropin-releasing hormone is dispersed homogeneously in and adsorbed homogeneously onto one or more gastric mucosa protecting or gastric mucosa tissue repairing agents selected form the group consisting of gefarnate, aceglutamide aluminum, sucralfate, L-glutanine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, and troxipide. 7. A nasally administrable composition wherein human growth hormone is dispersed homogeneously in and adsorbed homogeneously onto one or more gastric mucosa protecting or gastric mucosa tissue repairing agents selected from the group consisting of gefarnate, aceglutamide aluminum, sucralfate, L-glutamine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, and troxipide. 8. A method of stabilizing a physiologically active peptide, comprising combining the physiologically active peptide with one or more gastric mucosa protecting or gastric mucosa tissue repairing agents selected from the group consisting of gefarnate, aceglutamide aluminum, sucralfate, L-glutamine, sofalcone, teprenone, plaunotol, rebamipide, aldioxa, cetraxate and troxipide in the nasally administrable composition according to claim 1. 9. A method of treating a patient with a physiologically active peptide comprising nasally administering to a patient in need thereof, a composition according to claim 1.

Details for Patent 5,908,824

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2015-11-01
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.